The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for Y Kanda


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structural development of stabilized helical peptides as inhibitors of estrogen receptor (ER)-mediated transcription.EBI
National Institute of Health Sciences
Lithocholic Acid Derivatives as Potent Vitamin D Receptor Agonists.EBI
Ochanomizu University
Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.EBI
Pharmaceutical Research Institute
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 3: Structure-activity relationships of pyrropyrazolone derivatives.EBI
Shionogi
Discovery and synthesis of a potent sulfonamide ET(B) selective antagonist.EBI
Shionogi
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists Part 2: Discovery of orally bioavailable compounds.EBI
Shionogi
Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity.EBI
National Institute of Advanced Industrial Science and Technology (Aist)